CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 78 filers reported holding CUE BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 755,028 | $2,755,852 | 0.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 403,402 | $1,472,417 | 0.46% |
| Monaco Asset Management SAM | 370,407 | $1,351,986 | 0.38% |
| Slate Path Capital LP | 2,402,455 | $8,768,961 | 0.32% |
| CHANNEL WEALTH LLC | 68,700 | $250,755 | 0.14% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,746,525 | 0.12% |
| ADVISORY RESEARCH INC | 257,225 | $938,871 | 0.12% |
| Annandale Capital, LLC | 65,000 | $237 | 0.07% |
| SANDERS MORRIS HARRIS LLC | 56,420 | $198,722 | 0.04% |
| CARLSON CAPITAL L P | 134,036 | $489,231 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 58,663 | $214,120 | 0.04% |
| Good Life Advisors, LLC | 76,000 | $277,400 | 0.03% |
| Sigma Planning Corp | 225,300 | $822,345 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 37,762 | $137,831 | 0.01% |
| Nantahala Capital Management | 26,760 | $97,674 | 0.01% |
| Newbridge Financial Services Group, Inc. | 5,000 | $18,250 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 18,269 | $67 | 0.01% |
| SeaCrest Wealth Management, LLC | 14,000 | $51,100 | 0.01% |
| Jump Financial, LLC | 42,900 | $156,585 | 0.01% |
| Baker Avenue Asset Management, LP | 32,378 | $118,180 | 0.01% |
External links
This page lists CUE BIOPHARMA INC's shareholders in Q2 2023. To view CUE BIOPHARMA INC's shareholder history, click here.